Pharmicell Co., Ltd (005690) Financial Statements

― Followers

Pharmicell Co., Ltd Financial Overview

Pharmicell Co., Ltd's market cap is currently ₩714.49B. The company's EPS TTM is ₩775.86; its P/E ratio is 15.35; Pharmicell Co., Ltd is scheduled to report earnings on August 12, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	₩ 114.06B	₩ 64.85B	₩ 56.23B	₩ 60.18B	₩ 51.81B
Gross Profit	₩ 50.01B	₩ 21.33B	₩ 14.96B	₩ 23.82B	₩ 23.17B
Operating Income	₩ 33.78B	₩ 4.66B	₩ 951.00M	₩ 8.87B	₩ 7.86B
EBITDA	₩ 36.81B	₩ 9.43B	₩ 8.44B	₩ 8.90B	₩ 12.87B
Net Income	₩ 40.33B	₩ 6.33B	₩ 3.58B	₩ 8.26B	₩ 9.45B
Balance Sheet
Cash & Short-Term Investments	₩ 56.84B	₩ 11.20B	₩ 14.03B	₩ 25.96B	₩ 36.24B
Total Assets	₩ 157.42B	₩ 99.26B	₩ 92.52B	₩ 112.69B	₩ 95.81B
Total Debt	₩ 14.59B	₩ 686.00M	₩ 3.03B	₩ 16.84B	₩ 17.25B
Net Debt	₩ -14.27B	₩ -7.57B	₩ -10.70B	₩ 2.49B	₩ -8.96B
Total Liabilities	₩ 33.54B	₩ 12.83B	₩ 12.12B	₩ 32.98B	₩ 30.46B
Stockholders' Equity	₩ 123.88B	₩ 86.44B	₩ 80.40B	₩ 76.66B	₩ 63.87B
Cash Flow
Free Cash Flow	₩ 33.60B	₩ -839.98M	₩ 5.79B	₩ -11.04B	₩ -9.54B
Operating Cash Flow	₩ 41.05B	₩ 3.50B	₩ 11.81B	₩ 7.91B	₩ -5.22B
Investing Cash Flow	₩ -32.33B	₩ -6.80B	₩ 5.92B	₩ -20.53B	₩ -9.35B
Financing Cash Flow	₩ 12.48B	₩ -3.22B	₩ -18.71B	₩ -269.81M	₩ 18.51B

Currency in KRW

Pharmicell Co., Ltd Earnings and Revenue History

Income Statement >

Pharmicell Co., Ltd Debt to Assets

Balance Sheet >

Pharmicell Co., Ltd Cash Flow

Cash Flow >

Pharmicell Co., Ltd Forecast EPS vs Actual EPS

Earnings >